Pronova Biopharma (PRON)

Sector:

Medicine and Biotech Research

Index:

OSE All Share

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

Nk 8.00
   
  • 52 Week High: Nk10.55
  • 52 Week Low: Nk5.00
  • Currency: Norway Kroner
  • Shares Issued: 300.83m
  • Market Cap: Nk2,406.66m

PRON Overview

Pronova BioPharma is engaged in the research, development and manufacture of omega-3 derived pharmaceutical products. Its first commercialised product is branded as Omacor in Europe and Asia and as Lovaza in the United States. The product is manufactured

3 Month Chart

3 Month Chart

1 Year Chart

1 Year Chart

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn 17.0%
ROCE 6.2%
Latest F'cast
P/E 24.2
PEG n/a
Pr/Revenue 1.5
Pr/Book 1.6
Latest F'cast
Revenue -8.2%
PBT -55.4%
EPS -57.1%
DPS n/a

PRON Fundamentals

Year Ending Revenue (Nkm) Pre-tax (Nkm) EPS P/E PEG EPS Grth. Div Yield
31-Dec-07 1,013.84 201.96 1.07Nk 20.6 n/a n/a n/a 0.0%
31-Dec-08 1,301.50 468.89 1.46Nk 15.8 0.4 +36% n/a 0.0%
31-Dec-09 1,789.82 321.64 0.77Nk 22.9 n/a -47% n/a 0.0%
31-Dec-10 1,643.75 143.32 0.33Nk 28.5 n/a -57% n/a 0.0%

PRON Forecasts

Year Ending Revenue (Nkm) Pre-tax (Nkm) EPS P/E PEG EPS Grth. Div Yield
31-Dec-11 1,668.87 208.79 0.67Nk 11.9 0.1 +104% 0.50Nk 7.5%
31-Dec-12 1,811.98 307.21 0.96Nk 8.3 0.2 +43% 0.64Nk 9.5%
31-Dec-13 1,963.60 459.12 1.28Nk 6.2 0.2 +34% 0.75Nk 11.1%

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

PRON Market Data

Currency Norway Kroner
% Change 6.67 %
52 Week High Nk10.55
52 Week Low Nk5.00
Shares Issued 300.83m
Market Cap Nk2,406.66m

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 3
Sell 0
Strong Sell 1
Total 5
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page